Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Multicentre Phase III Study of Short Course Radiation Therapy Followed by Prolonged Pre-operative Chemotherapy and Surgery in Primary High Risk Rectal Cancer Compared to Standard Chemoradiotherapy and Surgery and Optional Adjuvant Chemotherapy.

NCT01558921 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT01558921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01558921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Multicentre Phase III Study of Short Course Radiation Therapy Followed by Prolonged Pre-operative Chemotherapy and Surgery in Primary High Risk Rectal Cancer Compared to Standard Chemoradiotherapy and Surgery and Optional Adjuvant Chemotherapy.
Lead sponsor
University Medical Center Groningen
Phase
Phase 3
Overall status
Active, not recruiting
Start date
June 21, 2011
Completion date
December 31, 2026
Enrollment
920 (actual)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer